Efficacy of intravitreal triamcinolone acetonide in the visualization of the vitreous during pars plana vitrectomy;Zastosowanie octanu triamcinolonu w celu wizualizacji ciała szklistego w przebiegu witrektomii pars plana

Klinika Oczna

Volumn 108, Issue 1-3, 2006, Pages 24-27

  Mańkowska, Anna ^a,b   Rejdak, Robert ^a   Nowomiejska, Katarzyna ^a   Zagórski, Zbigniew ^a  

^a Z Katedry i I Kliniki Okulistyki Akademii Medycznej w Lublinie   (Poland)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Pars plana vitrectomy; Triamcinolone acetonide; Vitreous body

Indexed keywords

DIAGNOSTIC AGENT; GLUCOCORTICOID; TRIAMCINOLONE ACETONIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; BASEMENT MEMBRANE; CHILD; EVALUATION; EYE DISEASE; FEMALE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VITRECTOMY; VITREOUS BODY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BASEMENT MEMBRANE; CHILD; EYE DISEASES; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; VITRECTOMY; VITREOUS BODY;

EID: 34447503543     PISSN: 00232157     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Machemer R., Sugita G., Tano Y: Treatment of intraocular proliferations with intravitreal steroids. Trans. Am. Ophthalmol. Soc., 1979, 77, 171-180.
2. Tano Y, Chandler D., Machemer R.: Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide. Am. J. Ophthalmol., 1980, 90, 810-816.
3. Machemer R.: Five cases in which a depot steroid (hydrocortisone acetate and methylprednisolone acetate) was injected into the eye. Retina, 1996, 16(2), 166-167.
4. Danis R.R, Ciulla T.A., Pratt L.M., Anliker W.: Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina, 2000, 20, 244-250.
5. Jonas J.B., Hayler J.K., Panda-Jonas S.: Intravitreal injection of crystalline cortisone as adjunctive treatment of proliterative vitreoretinopathy. Br. J. Ophthalmol., 2000, 84, 1064-1067.
6. Sakamoto T., Miyazaki M., Hisatomi T. et al: Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown. Graefes Arch. Clin. Exp. Ophthalmol., 2002, 240, 423-429.
7. Peyman G.A., Cheema R., Conway M.D., Fang T.: Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloid during pars plana Vitrectomy. Retina, 2000, 20(5), 554-555.
8. Enaida H., Hata Y., Ueno A., Nakamura T., Hisatomi T., Miyazaki M., Fujisawa K., Sakamoto T., Ishibashi T.: Possible benefits of triamcinolone-assisted pars plana vitrectomy for retinal diseases. Retina, 2003, 23(6), 764-770.
9. Furino C., Micelli Ferrari T., Boscia F., Cardascia N., Recchimurzo N., Sborgia C.: Triamcinolone-assisted pars plana vitrectomy for proliferative vitreoretinopathy. Retina, 2003, 23(6), 771-776.
10. Shah G.K., Rosenblatt B.J., Smith M.: Internal limiting membrane peeling using triamcinolone acetonide: histopathologic confirmation. Am. J. Ophthalmol., 2004, 138(4), 656-657.
11. Tognetto D., Zenoni S., Sanguinetti G., Haritoglou C., Ravalico G.: Staining of the internal limiting membrane with intravitreal triamcinolone acetonide. Retina, 2005, 25(4), 462-467.
12. Pel-Przybyszewska E., Szkudlarek E., Szkudlarek A., Nawrocki J.: Trypan blue staining in treatment of macular hole. Klin. Oczna, 2004, 106(3 Suppl.), 503-505.
13. Lee J.E., Yoon T.J., Oum B.S., Lee U.S., Choi H.Y.: Toxicity of indocyanine green injected into the subretinal space: subretinal toxicity of indocyanine green. Retina, 2003, 23, 675-681.
14. McCuen B.W. 2nd, Besler M., Tano Y., Chandler D., Machemer R.: The lack of toxicity of intravitreally admininstred triamcinolone acetonide. Am. J. Ophthalmol., 1981, 91, 785-788.
15. Sakamoto T., Enaida H., Kubota T. et al.: Incidence of acute endophthalmitis after triamcinolone-assisted pars plana vitrectomy. Am. J. Ophthalmol., 2004, 138, 137-138.